Chemoinformaics analysis of 7-HYDROXY-8-METHOXYCHROMEN-2-ONE
| Molecular Weight | 192.17 | nRot | 1 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 12 |
| Exact Molecular Weight | 192.042 | nRing | 2 |
| Solubility: LogS | -2.267 | nHRing | 1 |
| Solubility: LogP | 1.198 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 25.2423 |
| nHD | 1 | BPOL | 12.3657 |
| QED | 0.695 |
| Synth | 2.266 |
| Natural Product Likeliness | 1.644 |
| NR-PPAR-gamma | 0.214 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.023 |
| HIA | 0.007 |
| CACO-2 | -4.738 |
| MDCK | 0.0000202 |
| BBB | 0.109 |
| PPB | 0.872133 |
| VDSS | 0.7 |
| FU | 0.186737 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.938 |
| CYP2c19-inh | 0.166 |
| CYP2c19-sub | 0.08 |
| CYP2c9-inh | 0.068 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.706 |
| CYP2d6-sub | 0.674 |
| CYP3a4-inh | 0.434 |
| CYP3a4-sub | 0.257 |
| CL | 14.13 |
| T12 | 0.858 |
| hERG | 0.026 |
| Ames | 0.514 |
| ROA | 0.303 |
| SkinSen | 0.381 |
| Carcinogencity | 0.888 |
| EI | 0.785 |
| Respiratory | 0.254 |
| NR-Aromatase | 0.331 |
| Antiviral | No |
| Prediction | 0.762794 |